Abstract

e19550 Background: Evaluating the benefit of esicosapentaenoic acid (EPA) nutrition supplement in nasopharyngeal cancer (NPC) patients who receiving concomitant chemoradiotherapy Methods: Patients ...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Potentially improved response of COVID-19 vaccinated nasopharyngeal cancer patients to combination therapy with anti-PD-1 blockade and chemotherapy
Y.J Hua ... J Li
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 34
Y.J Hua, et. al.Y.J Hua ... J Li
07 Oct 2022
Survival-Weighted Health Profiles in Nasopharyngeal Cancer Patients
Chia-Hsuan Lai ... Chiung-Cheng Fang
Frontiers in Oncology | VOL. 11
Chia-Hsuan Lai, et. al.Chia-Hsuan Lai ... Chiung-Cheng Fang
15 Mar 2021
Rationale for different formulations of omega-3 fatty acids leading to differences in residual cardiovascular risk reduction
R Preston Mason ... Robert H Eckel
Metabolism | VOL. 130
R Preston Mason, et. al.R Preston Mason ... Robert H Eckel
10 Feb 2022
Biofilm Formations in Nasopharyngeal Tissues of Patients with Nasopharyngeal Osteoradionecrosis
Yih‐Jeng Tsai ... Po‐Han Chiu
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery | VOL. 148
Yih‐Jeng Tsai, et. al.Yih‐Jeng Tsai ... Po‐Han Chiu
24 Jan 2013
View more papers

More From: Journal of Clinical Oncology

Paper Title
Journal
Date
Author
Erratum: Neoadjuvant Chemotherapy in High-Grade Myxoid Liposarcoma: Results of the Expanded Cohort of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish Sarcoma Groups (PSG).
-
Journal of Clinical Oncology | VOL. -
--
03 Jul 2024
Denosumab Prevents Bone Loss and Microarchitectural Deterioration in Premenopausal Women With Breast Cancer Receiving Estradiol Suppression Therapy: A Randomized Controlled Trial.
Sabashini K Ramchand ... Mathis Grossmann
Journal of Clinical Oncology | VOL. -
Sabashini K Ramchand, et. al.Sabashini K Ramchand ... Mathis Grossmann
02 Jul 2024
Final Results From a Phase I Trial and Expansion Cohorts of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced/Metastatic Genitourinary Tumors.
Andrea B Apolo ... Amir Mortazavi
Journal of Clinical Oncology | VOL. -
Andrea B Apolo, et. al.Andrea B Apolo ... Amir Mortazavi
02 Jul 2024
Open-Label, Multicenter, Phase I/II, First-in-Human Trial of TK216: A First-Generation EWS::FLI1 Fusion Protein Antagonist in Ewing Sarcoma.
Paul A Meyers ... Joseph A Ludwig
Journal of Clinical Oncology | VOL. -
Paul A Meyers, et. al.Paul A Meyers ... Joseph A Ludwig
02 Jul 2024
View more papers